Colgate-Palmolive Q1 sales beat estimates on broad-based growth

Colgate-Palmolive

01/05/2026 12:04

Overview

Consumer products maker's Q1 net sales rose 8.4%, beating analyst expectations

Adjusted EPS for Q1 grew 7% and beat analyst expectations

Company expanded Strategic Growth and Productivity Program, raising projected charges and savings

Outlook

Colgate-Palmolive maintains 2026 net sales growth guidance of 2% to 6%

Company now expects 2026 gross profit margin to be down, versus up previously

Colgate-Palmolive expects volatile macroeconomic conditions and slower category growth to continue in 2026

Result Drivers

BROAD-BASED SALES GROWTH - Co said net and organic sales grew in every category and in four of five divisions, with both pricing and volume contributing

PRIVATE LABEL PET FOOD EXIT - Organic sales growth was negatively affected by lower private label pet food sales

HIGHER ADVERTISING SPENDING - Advertising spending increased year over year

Company press release: ID:nBw1SbSpda

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
Beat
$5.32 bln
$5.22 bln (12 Analysts)
Q1 Adjusted EPS
Beat
$0.97
$0.95 (16 Analysts)
Q1 EPS
$0.80


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", 8 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the personal products peer group is "buy"

Wall Street's median 12-month price target for Colgate-Palmolive Co is $98.00, about 14.8% above its April 30 closing price of $85.36

The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 23 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)